Stockwinners Market Radar for February 28, 2020 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:57 EST AbbVie says Phase 3 trial of venetoclax combo did not meet primary endpoint - AbbVie announced the VIALE-C trial of venetoclax in combination with low-dose cytarabine versus LDAC in combination with placebo did not meet its primary endpoint of statistically significant improvement of overall survival for patients with acute myeloid leukemia who are ineligible for intensive chemotherapy at the time of the planned analysis.Treatment with the venetoclax combination showed a 25% reduction in the risk of death compared to LDAC with placebo. The venetoclax with LDAC arm also showed a median OS of 7.2 months vs. 4.1 months in the LDAC arm alone. A post-hoc analysis after an additional six months of follow up showed an increase in median OS of 8.4 months in the venetoclax plus LDAC arm and 4.1 months in the placebo plus LDAC arm.

18:31 EST Hudson Pacific cancels presentation at Citi 2020 Global Property CEO Conference - Hudson Pacific Properties announced the cancellation of the company's presentation and webcast at Citi's 2020 Global Property CEO Conference, previously scheduled to take place on Tuesday, March 3, at 11:00 a.m. ET. Management no longer plans to attend the conference in light of a growing list of cancellations.

17:49 EST Wolverine World Wide's Jeppesen sells 45,493 common shares - In a regulatory filing, Wolverine World Wide's president of Global Operations and Heritage Groups Michael Jeppesen disclosed the sale of 45,493 common shares of the company on February 27 at a price of $27.65 per share.

17:35 EST Lockheed Martin Comments awarded $141.66M Navy contract modification - Lockheed Martin was awarded a $141.66M modification to a previously awarded fixed-price-incentive-firm-target contract. This modification provides for the stand-up of organic level repair capabilities for the combat aircraft F-35 communications, navigation and information system. Work is expected to be completed by June 2024. FY19 aircraft procurement funds in the amount of $70.83M, FY19 aircraft procurement funds in the amount of $35.41M and FY19 aircraft procurement funds in the amount of $35.41M will be obligated at time of award, none of which will expire at the end of the current fiscal year. The Naval Air Systems Command is the contracting activity.

17:26 EST General Motors to hire 1,200 new workers for Michigan plants, Bloomberg reports - General Motors announced it will hire 1,200 new workers for its two plants in Lansing, Michigan, partly due to rising demand for the company's mid-sized sport utility vehicles, Bloomberg's David Welch reports. The company plans to add a third shift and 800 workers at its Lansing Delta Township plant, where it builds the Chevrolet Traverse and Buick Enclave SUVs. GM also will institute a second shift, including 400 new hires, at its Lansing Grand River factory. That facility makes the Chevy Camaro sports car and the all-new Cadillac CT4 and CT5 sedans. Reference Link

17:20 EST Vectrus awarded $121.78M Army contract modification - Vectrus was awarded a $121.78M modification to a contract for continued support of critical operation, maintenance and defense of Army communications. Work will be performed in Kuwait, with an estimated completion date of August 28. FY20 operations and maintenance funds in the amount of $121.78M were obligated at the time of the award. U.S. Army Contracting Command is the contracting activity.

17:01 EST Acasti receves Nasdaq notification over minimum bid requirements - Acasti Pharma announced that on February 28, 2020, it received written notification from the Nasdaq Listing Qualifications Department for failing to maintain a minimum bid price of U.S.$1.00 per share for the last 30 consecutive business days, as required by Nasdaq Listing Rule 5550a2 - bid price. The Nasdaq notification has no immediate effect on the listing of Acasti Pharma's shares. Under Nasdaq Listing Rule 5810c3A - compliance period, Acasti Pharma has 180 calendar days, or until August 26, 2020, to regain compliance. If at any time over this period the bid price of Acasti Pharma's shares closes at $1.00 per share or more for a minimum of ten consecutive business days, Nasdaq will provide written confirmation of compliance and the matter will be closed.

16:51 EST Camber Energy discloses listing compliance notice from NYSE - Camber Energy announced that on February 24, 2020, it was notified by the NYSE American that the company was not in compliance with certain of the Exchange's continued listing standards .Specifically, Camber is not in compliance with Section 1003(a)(ii) of the Company Guide in that it reported stockholders' equity of $3.1 million as of December 31, 2019 and net losses in three of four of its most recent fiscal years then ended, meaning specifically that Camber is not in compliance with Section 1003(a)(ii) of the Company Guide which requires listed companies have stockholders' equity of $4,000,000 or more and not have sustained losses from continuing operations and/or net losses in three of four of such issuer's most recent fiscal years. In order to maintain its listing on the Exchange, the Exchange has requested that the company submit a plan of compliance by March 25, 2020, addressing how it intends to regain compliance with Section 1003(a)(ii) of the company Guide by August 24, 2021. The company's management is beginning its analysis regarding submission of a Plan to the Exchange by the required due date.

16:32 EST Gulf Resources receives approval to resume bromine production in Shouguang - Gulf Resources announced that it has received a notification from the government of Shouguang City, pursuant to which the company's bromine facilities has been allowed to resume production. On November 25, 2019, the government of Shuoguang City issued a notice ordering all bromine facilities in Shouguang City, including the company's bromine facilities, to temporarily stop production from December 16, 2019 to February 10. Subsequently, due to the coronavirus outbreak in china, the local government ordered those bromine facilities to postpone the commencement of production. The Company has received an approval to resume its bromine production issued by Shouguang Comprehensive Coordination Group for Epidemic Prevention and Control.

16:30 EST Harley-Davidson president, CEO Matthew Levatich steps down - Harley-Davidson announced that Matthew Levatich has stepped down as President and CEO and as a member of the Board of Directors. The Board of Directors has appointed current Board member Jochen Zeitz as Acting President and CEO. A committee of the Board will be formed, and the Company will utilize an external search firm to undertake a search for a new CEO, and a further announcement will be made at a later date. Levatich will assist with the transition through the end of March. As part of this leadership change, Jochen Zeitz has also been named Chairman of the Board and will remain Chairman once a new CEO is appointed. Current Chairman of the Board, Michael Cave, is now Presiding Director.

16:23 EST Sanofi enters $11.9M settlement relating to financial donations from 2015, 2016 - Sanofi U.S. announced that it has reached an $11.85M settlement agreement with the federal government to resolve an investigation relating to certain financial donations made in 2015 and 2016 to an independent charity patient assistance foundation that aided patients living with multiple sclerosis. As part of the settlement, Sanofi U.S. has also entered into a Corporate Integrity Agreement with the Office of the Inspector General of the U.S. Department of Health and Human Services. Many of the requirements are already incorporated into the Company's existing U.S. compliance program.

16:16 EST AvalonBay sees established community rental revenue in January-February up 3.1% - AvalonBay announced that it expects total rental revenue for Established Communities for the two months ending February 29, 2020 to increase 3.1% over the prior year period. This is 10 basis points above what the company's expectation was for total rental revenue growth during this period when the company published its outlook for full year Established Communities rental revenue growth on February 5, 2020.

16:13 EST Edison International's Southern California Edison names Jennifer Hasbrouck as GC - Jennifer Hasbrouck has been named senior vice president and general counsel for Southern California Edison, effective May 2. Hasbrouck will be responsible for all of the company's legal affairs. She succeeds Russell Swartz, who is retiring after a 27-year career at SCE. Hasbrouck joined SCE in 1999 and currently serves as an assistant general counsel.

16:06 EST Lilis Energy closes sale of undeveloped acreage - Lilis Energy announced that it has closed the previously announced sale of approximately 1,146 undeveloped net acres in the companys northernmost acreage in Lea County, New Mexico. The net cash proceeds of approximately $24.1M will be used to fund the first two borrowing base deficiency installment payments under the amended revolving credit agreement aggregating $17.25M, with the balance to be used for general corporate purposes. Two subsequent installment payments of $1.5M and $6.25M remain due on March 16, 2020 and April 14, 2020, respectively.

16:04 EST FDA grants Pfizer approval for Advil Dual Action - The FDA granted approval for Advil Dual Action to Pfizer, according to a post the agency's website.

15:58 EST Chatham Asset Management demands R.R. Donnelley revoke Poison Pill provision - Chatham Asset Management, LLC, a private investment firm which manages funds that beneficially own 12.9% of the outstanding common stock and which is the largest bondholder of R.R. Donnelley & Sons Company, sent a letter to RRD's Board of Directors urging the Board to immediately revoke or revise the provisions of the restrictive stockholder rights plan adopted by the company as of August 28, 2019. "Following the Company's recent publication of its fourth quarter and annual results for the period ended December 31, 2019, and the related conference call on February 26, 2020, we were utterly disappointed by the lack of any coherent response by management to the valid concerns we have raised," the letter reads. "Consequently, we determined to amend our prior regulatory filing on Schedule 13G, and commence reporting on Schedule 13D in order to maintain the maximum flexibility to effectuate necessary changes at the Company." Chatham added that the previously adopted "Poison Pill" stockholder rights plan contains provisions that may be interpreted to cause investors who no longer make regulatory filings on Schedule 13F to have tripped the Poison Pill threshold to the extent their beneficial ownership of the Company's common stock exceeds 10%. "The applicable threshold for all other investors is 20%," Chatham said. "The effect is that any such investors whose change in intent causes them no longer to qualify as "ordinary course institutional investors" are required to reduce their beneficial ownership position to below 10% within 30 days, or trigger the Poison Pill. Moreover, such provisions appear to apply to us notwithstanding that our affiliated funds have not purchased a single additional share since the Company's precipitous and unlawful adoption of the Poison Pill on August 28, 2019." "We are no longer content to stand idly by, while hundreds of millions of dollars' worth of value for all of the Company's stakeholders are blithely frittered away by a group of entrenched, inactive and incompetent leaders," the letter continued. "However, we are now faced with an untenable dilemma - sell our position below 10%, by no later than March 27, 2020, into a rapidly declining market that significantly undervalues the Company's true worth, or alternatively, face the crippling effects of dilution under the Poison Pill. This all as a penalty for doing no more than to exercise our most basic and fundamental right as a stockholder - raising our voices, making our positions known, and preserving our core ability to advocate for certain vitally necessary changes at the Company. We therefore demand that the board of directors and management take swift and immediate action to revoke the Poison Pill; and if not that, to revise the above-referenced provisions that have such an unconscionable effect on investors in a position such as ours. Please be advised that we are prepared to initiate appropriate litigation against you and the Company if your response proves to be untimely or inadequate. We would view any such litigation as an unfortunate waste of our, your and the Company's valuable time and resources, so we hope that you will not make it necessary for us to pursue that path to protect the legitimate interests of all stakeholders.

15:40 EST Sanofi to pay $11.85B to resolve DOJ claims over kickbacks - The U.S. Attorney's Office announced that pharmaceutical company Sanofi-Aventis U.S., LLC, has agreed to pay $11.85M to resolve allegations that it violated the False Claims Act by paying kickbacks to Medicare patients through a purportedly independent charitable foundation, The Assistance Fund. The government alleged that TAF, an entity claiming 501(c)(3) status for tax purposes, operates funds, including a fund for MS patients, that pay the co-pays of certain patients, including Medicare patients, who were prescribed Lemtrada. TAF allegedly raised its maximum per-patient grant allocation to $20,000 specifically to accommodate Lemtrada patients. During the relevant time period, TAF's MS fund frequently ran out of funding and was closed to new patients. If any patients applied for co-pay assistance at a time when the MS fund was out of funding and closed to new patients, TAF did not maintain a wait list of such patients. As a consequence, whenever TAF's MS fund opened to new patients, the fund provided grants to the patients who applied immediately after the opening and did not provide grants to patients who had sought to apply earlier but at a time when the fund was closed. The United States further alleged that Sanofi made payments to TAF not with a charitable purpose but rather with the intention of using TAF as a conduit to pay the financial obligations, including Medicare co-pay obligations, of patients taking Lemtrada, and that Sanofi's payment through TAF of Medicare co-pays for Lemtrada violated the Anti-Kickback Statute. To effectuate its scheme, Sanofi worked with its third-party reimbursement hub to identify Medicare patients for whom physicians had prescribed Lemtrada, but who had not yet received infusions of the drug because they lacked sufficient funds to afford the co-pays for Lemtrada. Sanofi made nine payments to TAF during 2015 and 2016. At the times Sanofi made eight of these nine payments, TAF's MS fund had run out of funding, and was closed to new patients. In conjunction with its payments to TAF, and knowing that TAF's MS fund did not maintain wait lists and would fund the first patients who applied for assistance after the fund received new funding, Sanofi instructed its hub quickly to refer as many Lemtrada patients as possible to the TAF MS fund. As a result, when TAF's MS fund opened with funding from Sanofi, Lemtrada patients received a disproportionately large share of the Medicare co-pay grants TAF issued and patients taking MS drugs other than Lemtrada received a disproportionately small share of the Medicare co-pay grants TAF issued.

15:02 EST Microchip says will not attend any investor conferences for remainder of quarter - Microchip announced that it will provide a business update on its March 2020 quarter on Monday, March 2 after market close. This update will include a conference call and webcast that will begin at 5:00PM ET. Additionally, the company announced that it will not be attending any investor conferences for the remainder of the quarter, due to company travel restrictions associated with the Coronavirus. These conferences include the Morgan Stanley 2020 Technology, Media & Telecom Conference, the Raymond James 41st Annual Institutional Investor Conference, and the Susquehanna Financial Group Technology Conference. "The safety of our employees worldwide continues to remain paramount and we have taken precautionary steps to help ensure the health and safety of our employees and to control the impact on Microchip's operations," said Steve Sanghi, Microchip's CEO. "We regret the necessary last-minute cancellation of our attendance at these events, and we intend for our business update on March 2, 2020 to be a helpful update on business conditions for investors and analysts."

14:58 EST Western Copper appoints Varun Prasad CFO - Varun Prasad has been appointed to the position of CFO of Western, which appointment will become effective March 1. Prasad has worked on the Finance team for Western since 2011, previously as Corporate Controller and most recently as interim CFO.

14:32 EST Rizk Ventures reiterates 'no longer interested in' bid for Mack-Cali Realty - Rizk Ventures released two letters previously sent to the board of Mack-Cali Realty (CLI). Rizk Ventures released these letters to respond to and to clarify comments made by the CEO of Mack-Cali during the February 27 earnings call in connection with Rizk Ventures credible, financed expression of interest in acquiring Mack-Cali Realty. Rizk Ventures reiterated its position that it is no longer interested in making a bid for Mack-Cali.

14:19 EST L3Harris Technologies increases quarterly dividend 13% to 85c per share - L3Harris Technologies has declared a quarterly cash dividend of 85c per share on the common stock, payable March 27, to shareholders of record on the close of business on March 13.

14:15 EST Tutor Perini trading resumes

14:10 EST Tutor Perini trading halted, volatility trading pause

14:04 EST FCC proposes over $200M in fines for wireless location data violations - The Federal Communications Commission announced that it has proposed fines against the nation's four largest wireless carriers for apparently selling access to their customers' location information without taking reasonable measures to protect against unauthorized access to that information. As a result, T-Mobile (TMUS) faces a proposed fine of more than $91M; AT&T (T) faces a proposed fine of more than $57M; Verizon (VZ) faces a proposed fine of more than $48M; and Sprint (S) faces a proposed fine of more than $12M. The FCC also "admonished these carriers for apparently disclosing their customers' location information, without their authorization, to a third party," the FCC notice stated. Reference Link

13:21 EST Energy Transfer reports supplemental open season for Bayou Bridge system - Energy Transfer LP announced that its subsidiary, Bayou Bridge Pipeline, LLC, launched a Binding Supplemental Open Season to solicit additional shipper commitments for transportation service from Nederland, Texas to Lake Charles, Louisiana through the Bayou Bridge Pipeline System. Bayou Bridge anticipates that incremental capacity on the Bayou Bridge Pipeline System will be determined based on committed subscriptions made by shippers during the Open Season.

13:01 EST Baker Hughes reports U.S. rig count down 1 to 790 rigs

12:55 EST Kingsway Financial appoints Kent Hansen CFO - Kingsway Financial Services announced that Kent Hansen has been named CFO of the company, effective immediately, following the board's acceptance of the resignation of William Hickey, Jr. Hansen joined the company's indirect, wholly-owned subsidiary, Kingsway America, as its CFO in December 2019. Hickey has agreed to remain with the company in a consulting capacity at least through April 30, to ensure a smooth and successful transition of his role and responsibilities.

12:25 EST Trillium Therapeutics trading halted, news pending

12:06 EST ADP reports Perrotti steps down as President, Worldwide Sales and Marketing - In a regulatory filing earlier, Automatic Data Processing announced that Thomas Perrotti, President, Worldwide Sales and Marketing, will be stepping down from the company, effective as of June 30, "after nearly 27 years of service." The company also announced that Maria Black, President, Small Business Solutions and Human Resources Outsourcing, was appointed President, Worldwide Sales and Marketing, effective February 27. Perrotti will continue to serve as a corporate officer of the company for the transition period.

12:00 EST Big Lots falls -27.3% - Big Lots is down -27.3%, or -$6.12 to $16.32.

12:00 EST Direxion Daily Gold Miners Bear 3X ETF rises 14.7% - Direxion Daily Gold Miners Bear 3X ETF is up 14.7%, or 86c to $6.73.

12:00 EST Direxion Daily Junior Gold Miners Index Bear 3x Shares rises 18.5% - Direxion Daily Junior Gold Miners Index Bear 3x Shares is up 18.5%, or $1.93 to $12.40.

11:49 EST Novavax trading halted, volatility trading pause

11:16 EST Popular boosts dividend to 40c from 30c per share - Popular announced that its board of directors has approved a quarterly cash dividend of 40c per share on its outstanding common stock. The dividend will be payable on April 1 to shareholders of record at the close of business on March 19.

10:35 EST Shopify cancels in-person element of Unite conference over coronavirus - Shopify announced on it website, "Over the last two years, more than a thousand partners from all over the world have gathered in Toronto to hear about our vision for the future of commerce. Due to the evolving public health concerns around COVID-19, we've made a hard but necessary decision to cancel the in-person element of Shopify Unite this year. We believe this is the best option to make sure we don't put anyone's health and safety at risk. We'll share more updates in the coming weeks." Reference Link

10:11 EST Biofrontera AG (ADS) trading halted, volatility trading pause

10:00 EST Wayfair falls -17.3% - Wayfair is down -17.3%, or -$12.16 to $58.19.

10:00 EST Glaukos falls -28.1% - Glaukos is down -28.1%, or -$17.27 to $44.20.

10:00 EST Direxion Daily Gold Miners Bear 3X ETF rises 15.0% - Direxion Daily Gold Miners Bear 3X ETF is up 15.0%, or 88c to $6.75.

09:59 EST CannTrust receives continued listing notice from the NYSE - CannTrust Holding announced that on February 27, 2020 the Company received written notification from the New York Stock Exchange that CannTrust is no longer in compliance with the NYSE's continued listing standard rules because the per share trading price of the Company's common shares has fallen below the NYSE's share price rule. The NYSE requires the average closing price of a listed company's common shares to be at least $1.00 per share over a consecutive 30 trading-day period. As of February 25, 2020, the 30 trading-day average closing price of the Company's common shares was 99c In accordance with the NYSE's rules, CannTrust has six months from the receipt of the notice to regain compliance. During this time period, the Company's common shares will continue to be listed and trade on the NYSE as usual. Under NYSE rules, CannTrust can regain compliance at any time during the six-month period if its common shares have a closing price of at least $1.00 on the last trading day of any calendar month during the period and also have an average closing price of at leas $1.00 over the 30 trading-day period ending on the last trading day of that month or on the last day of the cure period.

09:53 EST China Online Education trading resumes

09:48 EST China Online Education trading halted, volatility trading pause

09:47 EST Glaukos falls -32.6% - Glaukos is down -32.6%, or -$20.03 to $41.44.

09:47 EST ProShares Trust Ultra VIX Short Term Futures ETF rises 14.6% - ProShares Trust Ultra VIX Short Term Futures ETF is up 14.6%, or $3.17 to $24.88.

09:47 EST VSE Corp. trading halted, volatility trading pause

09:44 EST Vir Biotechnology Inc trading resumes

09:42 EST Alphatec trading resumes

09:39 EST Accelerate Diagnostics trading resumes

09:39 EST Moderna trading resumes

09:36 EST Foot Locker sees FY20 gross margin up 10-30 bps - Sees FY20: CapEx $275M; SG&A expense up 40-60 bps; Tax rate 27.5%-28%; FX a topline headwind, more pronounced in first half; 125 stores re-modeled/re-located; 150 store closures.

09:35 EST Acadia trading resumes

09:35 EST Standard General nominates additional director candidate for Tegna board - Standard General L.P., one of the largest shareholders of TEGNA and the owner of approximately 9.7% of the Company's outstanding shares, announced that, following TEGNA's expansion of its Board of Directors to 12 directors last week, it will nominate Lawrence Wert as an additional candidate for election to the TEGNA Board of Directors at the 2020 Annual Meeting of Shareholders. This brings Standard General's slate of candidates to five. Wert was President, Broadcast Media, of Tribune Media Company (TRCO) from February 2013 until the closing of Tribune's acquisition by Nexstar Media Group (NXST) in September 2019. The investment advisor said, "Unlike TEGNA's current Board, which does not have a single independent director with industry operating experience, Standard General's nominees bring significant operating experience in the local television broadcasting industry in addition to significant business and leadership experience with their backgrounds spanning strategic planning, finance, M&A, and technology. Collectively, they have decades of experience as CEOs, CFOs, COOs, and directors of well-performing broadcasting companies. They are committed to rigorous oversight of TEGNA's management, operations and business strategy."

09:34 EST Vir Biotechnology Inc trading halted, volatility trading pause

09:32 EST Nevada reports January Statewide gaming win up 5.48% to $1.038B - Reports January Las Vegas Strip gaming win up 7.49% to $572.125M. Publicly traded companies in the casino space include Boyd Gaming (BYD), Caesars (CZR), Las Vegas Sands (LVS), MGM Resorts (MGM), Penn National (PENN) and Wynn Resorts (WYNN).

09:32 EST Alphatec trading halted, volatility trading pause

09:31 EST Alpha Pro Tech trading halted, volatility trading pause

09:30 EST Acadia trading halted, volatility trading pause

09:15 EST American BriVision expects Phase II Part II study of ABV-1505 - ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder: A Phase II Part I clinical trial, under FDA clinical protocol code BLI-1008-001 for adult attention-deficit hyperactivity disorder, was initiated at the University of California San Francisco Medical Center in the fall of 2019. The primary objective of this study is to determine the effective doses and treatment period of PDC-1421, the active pharmaceutical ingredient in ABV-1505, in adult patients with ADHD. The secondary objective is to evaluate the safety of PDC-1421 in patients receiving the drug at various dose levels. A Phase II Part II study is expected to follow at the UCSF Medical Center, along with major medical centers in Taiwan, after and subject to successful completion of this Phase II Part I study. The Phase II clinical study with ABV-1505 for the treatment of adult ADHD patients is aiming to further expand PDC-1421's therapeutic indication.

09:11 EST American BriVision expects multi-site pivotal study for Vitargus in 2020 - ABV-1701/Vitargus is a Vitreous Substitute for Vitrectomy Surgery: A First-in-Human clinical study of ABV-1701, or Vitargus, used as a biodegradable vitreous substitute in patients under vitrectomy surgery for retinal detachment or vitreous hemorrhage, was successfully completed at the Sydney Eye Hospital in Australia. The feasibility clinical study results were reported by Dr. Andrew Chang, the principal investigator, at the Retina Subspecialty Day program of the American Academy of Ophthalmology 2019 Annual Meeting in San Francisco on October 11th. The study showed Vitargus was generally well-tolerated and effective as a vitreous substitute, and no apparent toxicity or serious adverse events directly caused by Vitargus were observed. Moreover, an exploratory analysis showed a statistically significant improvement in best corrected visual acuity from the baseline. Given the encouraging study results, a multi-national, multi-site pivotal study for Vitargus is planned in 2020.

09:03 EST Ocean Power signs letter of intent with BAP Precision for PowerBuoy - Ocean Power Technologies announced that it has signed a letter of intent with Taiwan-based BAP Precision to provide PowerBuoy joint surveillance solutions for government agency contract pursuits for policing territorial waters. OPT and BAP are initially focusing on solutions for multiple agencies of Southeast Asian island nations seeking to meet the challenges of protecting fisheries, trafficking, and foreign encroachment upon territorial waters. A combination of predictive satellite and tactical marine monitoring capabilities interfacing with a grid of interconnected PowerBuoy surveillance solutions has been proposed.

08:57 EST Delta Air Lines CFO Paul Jacobson to retire - In a regulatory filing, Delta announced that, "Paul Jacobson, Delta's CFO, is retiring after a remarkable career at Delta that spanned more than two decades. Jacobson will remain at Delta while a successor is named and throughout the transition. He joined the company in 1997 and was named CFO in 2012."

08:47 EST Nevro files patent infringement lawsuit against Nalu Medical in the U.S. - Nevro announced that it has filed a lawsuit for patent infringement against Nalu Medical. The lawsuit, filed in the United States District Court for the District of Delaware on February 28, asserts that Nalu is infringing Nevro's patents covering inventions relating to Nevro's groundbreaking Senza system and HF10 therapy.

08:46 EST Nevro, Stimwave reach settlement in patent infringement suit - Nevro announced the settlement of its patent infringement lawsuit against Stimwave Technologies. Stimwave has agreed to cease commercialization of all high frequency spinal cord stimulation systems worldwide. The lawsuit was filed in the United States District Court for the District of Delaware on February 14, 2019, and asserted, among other things, that Stimwave was infringing Nevro's patents covering inventions relating to Nevro's groundbreaking Senza system and HF10 therapy. In July 2019, the District of Delaware issued a preliminary injunction against Stimwave. Stimwave has now agreed to a permanent injunction under which Stimwave's products will not deliver spinal cord stimulation therapy that includes pulse frequencies between 1,500 Hz and 100,000 Hz. The agreement reached between Nevro and Stimwave will apply globally. The permanent injunction will be filed with the Delaware district court. After the court enters the permanent injunction, the case (including Stimwave's appeal of the preliminary injunction order) will be dismissed. As part of the permanent injunction filing, Stimwave acknowledges the validity of the patents Nevro asserted in the litigation.

08:38 EST Performant says information in Schedule 13D filing is 'inaccurate or incomplete' - Performant Financial issued the following statement in response to the Schedule 13D filed today with the U.S. Securities and Exchange Commission by 22NW Fund, LP: "The Performant Board of Directors and management team maintains open and ongoing discussions with all our shareholders, and we value any opinions and feedback that furthers our goal of growing our business and delivering increased shareholder value. We are aligned with and committed to acting in the best interests of the Company's shareholders, which is perhaps best evidenced by the significant ownership stakes across our Board of Directors and management. Furthermore, as the Company's largest shareholder, Parthenon DCS has not divested any shares of the Company since 2014. We would like to thank 22NW Fund, LP for sharing its concerns. However, as we communicated to them and which was referenced in their Schedule 13D filing, the material non-public information specified by 22NW Fund, LP in its Schedule 13D filing is either inaccurate or incomplete and based on dated information. To that end, on February 26, 2020, we issued a press release that provided an update on adjusted EBITDA guidance for the fourth quarter of 2019 and initial 2020 annual guidance ranges for revenue and adjusted EBITDA. As referenced in that press release, we anticipate reporting strong operational results in the fourth quarter of 2019 with revenue in the range of $43 million to $44 million and adjusted EBITDA in the range of $6.0 and $6.5 million. Furthermore, we believe these strong results will continue into 2020 as demonstrated by our current full-year 2020 revenue and adjusted EBITDA guidance ranges of $170 million to $180 million and $12 million to $15 million, respectively. As it relates to our long-term targets, we continue to be committed to our goal of achieving annual revenues of $200 million with 20% margins. However, we are excited about growth opportunities in front of us that may require additional investment from time to time. Should the right opportunity to invest in a significant and differentiated product offering that may fuel growth in our top line and expand margins present itself, we may consider that type of investment."

08:34 EST Phillips 66, Trafigura form 50/50 JV to develop offshore deepwater port project - Phillips 66 and Trafigura Group announced they have formed a 50/50 joint venture, Bluewater Texas Terminal, to develop an offshore deepwater port project located approximately 21 nautical miles east of the entrance to the Port of Corpus Christi. The proposed project, to be constructed by Phillips 66, will consist of up to two single point mooring buoys capable of fully loading very large crude carriers, or VLCCs, to export crude oil. The project is currently in the permitting stage. The joint venture owners expect to make a final investment decision later this year, pending permit approval and customer volume commitments that support the project meeting the owners' economic return thresholds. Trafigura has withdrawn its application to develop the Texas Gulf Terminals deepwater port facility that was submitted to the United States Maritime Administration, or MARAD, in July 2018. The Bluewater Texas joint venture combines the market position that Trafigura has built in the United States as an exporter and marketer of crude oil with Phillips 66's commercial expertise, existing infrastructure network on the U.S. Gulf Coast, and operating experience. The Bluewater Texas joint venture is working with the Port of Corpus Christi Authority to provide a safe and environmentally sustainable infrastructure for the export of crude oil to global markets while benefitting the regional economy.

08:31 EST America First Multifamily announces unit repurchase program up to 290k units - America First Multifamily Investors announced that the Board of Managers (the "Board") of Greystone AF Manager LLC, which is the general partner of the Partnership's general partner, has authorized a new program for the repurchase of up to 290,000 of the Partnership's outstanding Beneficial Unit Certificates representing assigned limited partnership interests.

08:25 EST Credicorp announces director candidates for 2020 shareholders meeting - Credicorp announced the director candidates for its 2020 Annual General Shareholders Meeting: Alexandre Gouvea recently retired as director at McKinsey&Co. He has 30 years of international experience at the firm and specializes in providing advice to financial services clients. Maite Aranzabal Harreguyl is a Spanish executive with an international career and relevant experience on Boards of listed companies, family companies and NGOs. She currently leads her own consulting company, which specializes in retail and real estate businesses, Alir Consulting and Trade, and participates as a member of the Board of Adolfo Dominquez. Antonio Abruna Puyol is an attorney-at-law with deep experience as a legal scholar and manager of academic institutions. Since 2018, Mr Abruna is Rector of Universidad de Piura, Peru, where he has had a long and successful career. In addition to the three new independent director candidates, Credicorp's Board of Directors proposes for re-election the following five existing directors: Luis Enrique Romero Belismelis, Raimundo Morales Dasso, Patricia Lizarraga Guthertz, Fernando Fort Marie, and Dionisio Romero Paoletti. For detailed information related to the professional backgrounds and qualifications of each of the existing directors, please refer to our latest 20-F filing. At the 2020 Annual General Shareholders Meeting, Juan Carlos Verme Giannoni, Benedicto Ciguenas Guevara, and Martin Perez Monteverde will retire from the Board.

08:21 EST Shell Midstream agrees to acquire additional assets from Shell - Shell Midstream Partners (SHLX) announced it has signed an agreement with its general partner to eliminate all incentive distribution rights and economic general partner interest in SHLX. SHLX has also entered into a Purchase and Sale Agreement with affiliates of its sponsor, Royal Dutch Shell (RDS.A), to acquire Shell's 79% interest in Mattox Pipeline Company LLC, which owns the Mattox Pipeline, and certain logistics assets at the Shell Norco Manufacturing Complex. As consideration for the assets and the elimination of IDRs, the sponsor will receive 160 million newly issued SHLX common units, plus $1.2 billion of Series A perpetual convertible preferred units at a price of $23.63 per unit. SHLX and the sponsor agree to eliminate all IDRs and economic GP interest in the Partnership. The Partnership acquires a 79% interest in the Mattox Pipeline Company LLC, which owns the Mattox Pipeline. The Mattox Pipeline serves the Shell operated Appomattox platform and transports oil into the Proteus and Endymion systems, which ultimately connect to onshore markets via the Clovelly, LA storage hub. SHLX acquires certain Norco logistics assets, which contain crude, chemicals, intermediate and finished product pipelines, storage tanks, docks, truck and rail racks, and supporting infrastructure. SHLX agrees to issue 160 million newly issued SHLX common units to the sponsor. The newly issued SHLX common units are anticipated to receive distributions beginning with those made for the second quarter of 2020. The current distribution structure for the IDRs is anticipated to remain in place for the distributions made for the first quarter of 2020. SHLX issues $1.2 billion of preferred units at a price of $23.63 per unit, which pay a 4.0 percent annual coupon rate. The units are convertible, at the sponsor's option, after approximately two years, and, at the Partnership's option, after approximately three years, in each case subject to certain conditions. In addition, the sponsor has agreed to waive $20 million of common unit distributions per quarter for four quarters, anticipated to begin with the distribution made for the second quarter of 2020. The Mattox Pipeline is a 90-mile, 24-inch system with a 300,000 barrel per day capacity that will move produced crude oil from Appomattox westward to the Proteus and Endymion pipeline systems and then onshore. The Mattox Pipeline is backed by a long-term contract with a monthly minimum quantity at a fixed transportation rate for the Appomattox and Vicksburg fields. The Mattox Pipeline is also strategically located for potential future tie-backs to the Appomattox host, such as Rydberg, Dover, Fort Sumter and other exploration projects. These potential fields are not subject to the MMQ and could present upside in the future. The Norco logistics assets to be acquired by SHLX consist of certain midstream assets at the Shell Norco Manufacturing Complex and are comprised of crude, chemicals, intermediate and finished product pipelines, storage tanks, docks, truck and rail racks, and supporting infrastructure. These assets are backed by take-or-pay contracts with wholly owned subsidiaries of Shell with an initial term of fifteen years and an option to extend for an additional five-year term. The acquisition of these manufacturing and chemicals midstream assets builds upon the Partnership's strategy to access assets across Shell's broad asset base. The transaction is expected to close in the second quarter of 2020 and is subject to regulatory approvals, including under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, and other customary closing conditions. Post-closing, SHLX's general partner will hold a non-economic GP interest in SHLX and approximately 270 million common units, representing approximately 69 percent of the total outstanding common units in SHLX. The terms of the acquisition and IDR elimination were approved by the Board of Directors of the general partner of SHLX based on the approval and recommendation of its conflicts committee, which consists entirely of independent directors.

08:18 EST LiveXLive Media sees 'substantial growth in viewership' in early 2020 - LiveXLive Media (LIVX) has entered the new decade with substantial growth in viewership, up 54% for the first six weeks of calendar year 2020 versus the same six-week period in 2019, and a surge in cross-platform social media engagement of over 340% on Facebook (FB), 80% on Instagram and 140% on Twitter (TWTR) in January 2020 versus December 2019.

08:15 EST Albemarle raises quarterly dividend 5% to 38.5c per share - The dividend, which has an annualized rate of $1.54, is payable April 1 to shareholders of record at the close of business as of March 13.

08:12 EST Summit Financial Group announces stock repurchase program up to 750k shares - Summit Financial Group announces its Board of Directors recently approved a stock repurchase program of up to 750,000 shares of its outstanding common stock. Shares repurchased will be made in management's discretion at prices it considers to be attractive and in the best interests of both the Company and its shareholders, subject to the availability of shares, general market conditions, the trading price of the shares, alternative uses for capital and the Company's financial performance. The program does not obligate Summit to repurchase any particular number of shares of common stock during any period, and it may be discontinued, suspended or restarted at any time at the Company's discretion.

08:09 EST Post Holdings reports fire with no injuries at Michael Foods location - Post Holdings reported a fire took place on the evening of February 27, 2020, at its Michael Foods farm operation in Bloomfield, NE. All employees were safely evacuated, and no injuries were reported. The cause of the fire has yet to be determined. The fire impacted less than 5% of the layer population of Michael Foods' internal and external layer network. Before considering the impact of the fire, Post management guidance for Adjusted EBITDA range of $1.22-$1.27B for fiscal year 2020 remains unchanged. The impact of the fire on Post's financial results, if any, has yet to be determined. To the extent the property and/or business interruption loss exceeds $2.5M, Post management expects to be reimbursed under insurance policies; however, costs may be incurred in different reporting periods than any insurance recovery.

08:08 EST Kratos Defense receives $16.5M electronic warfare system production award - Kratos Defense & Security Solutions announced that it has received an approximate $16.5M single award contract for microwave electronics products in support of an airborne electronic warfare system. This contract award is the initial production award for what is expected to be a long term, multi-year electronic warfare system upgrade across several hundred aerial platforms. Kratos is a leading provider of microwave electronic products in support of missile, radar, guided munitions, electronic warfare, communication and other programs and systems. For customer related, competitive and other considerations, no further information will be provided related to this contract award.

08:06 EST Elbit Systems to provide FMVDL amplifier module for F-35 Lightning II aircraft - Elbit Systems was selected by Cubic Mission Solutions to design and develop the Full Motion Video Data Link amplifier module for the communications suite of the F-35 Lightning II aircraft. The amplifier module is a critical component of increasing the aircraft's advanced sensor suite by providing enhanced situational awareness to both airborne and ground forces. The F-35 FMVDL modules will be designed and manufactured at Elbit Systems of America in Fort Worth, Texas.

08:04 EST PDL BioPharma enters cooperation agreement with Engine Capital - PDL BioPharma announced it has entered into a cooperation agreement with Engine Capital Management, which owns approximately 5.5% of the company's outstanding shares, pursuant to which Alan Bazaar will immediately join PDL's Board of Directors as a Class III director serving until the company's 2022 Annual Meeting of Stockholders. PDL has also agreed to form a Cost Committee of the Board, chaired by Bazaar, to oversee cost reduction initiatives and will present a proposal to declassify the Board at the 2020 Annual Meeting. Following the 2020 Annual Meeting, Bazaar will be appointed to the Compensation Committee of the Board, and PDL's Board will be comprised of seven directors, five of whom are independent. At that time, the company will have refreshed five of the seven seats on the Board since June 2018. Under the terms of the agreement, Engine has agreed to abide by customary standstill and voting provisions until the earlier of 30 days prior to the deadline for stockholder nominations of directors for the 2021 Annual Meeting or 120 days prior to the first anniversary of the 2020 Annual Meeting.

08:02 EST Arch Coal CEO John Eaves to retire, Paul Lang to succeed - Arch Coal announced that John Eaves will retire as Arch's CEO at the corporation's annual meeting on April 30, and will assume the position of executive board chair. James Chapman, who has served as Arch's board chair since the company completed its restructuring process in October 2016, will transition to lead independent director at that time. Paul Lang, Arch's president and COO, will succeed Eaves as CEO and is joining the board. Lang joined Arch in 1984 and - prior to his current role - served as Arch's executive vice president and COO.

07:42 EST Vislink announces inducement grant under Nasdaq listing rule - Vislink Technologies announced that on February 27, 2020 Michael Bond was granted a non-qualified stock option award to purchase a quantity of shares equal to one percent of the Company's fully diluted outstanding shares of its common stock as of April 1, 2020 under Nasdaq Listing Rule 5635(c)(4) outside of the Company's existing equity compensation plans, in connection with Mr. Bond's employment by the Company as its CFO. These options were granted as an inducement material to Mr. Bond becoming an employee of Vislink Technologies, Inc., in accordance with Nasdaq Listing Rule 5635(c)(4). The options will have an exercise price per share equal to the closing price of the Company's common stock on the Nasdaq Stock Market on April 1, 2020. 25% of the inducement options will vest on April 1, 2021 and the remaining 75% will vest in substantially equal monthly installments over the 36-month period thereafter, subject to Mr. Bond's continued employment by the Company on the applicable vesting date.

07:39 EST Camping World announces 7.32c per share special cash dividend - Camping World announced that its board declared a cash dividend of 15.32c per share on the company's Class A common stock and a cash distribution of 8c per common unit on CWGS Enterprises, LLC's common units. Payment is expected to be made on March 30 to stockholders of record at the close of business on March 16. The CWH Class A common stock cash dividend is comprised of a regular quarterly cash dividend of 8c per share funded by the 8c per common unit cash distribution by CWGS Enterprises, LLC to all holders of its common units, and a 7.32c per share special cash dividend representing a portion of excess tax distributions from CWGS Enterprises, LLC.

07:37 EST Spirit AeroSystems says accounting review 'now substantially complete' - On January 30, the company announced it was conducting a review of its accounting process compliance and had concluded that the company did not comply with its established accounting processes with respect to whether and when to accrue certain potential contingent liabilities received by the company after the end of the third quarter of 2019. The review is now substantially complete and the company concluded that it should have recorded an incremental contingent liability for the third quarter of 2019 of less than $8M. Although the company views this difference as immaterial and no restatement of financial statements is required, the matter led the company to conclude that a material weakness in our internal control over financial reporting existed as of December 31, 2019. The company has a corrective action plan in place and expects the material weakness in financial reporting to be fully remediated by the end of the year. Additional information on this material weakness will be described in the company's Annual Report on Form 10-K for 2019.

07:33 EST E.W. Scripps sees Q1 pro-forma local media revenue up 'low teens' - Sees Q1 national media revenue $105M-$110M.

07:21 EST Green Thumb says Rise Effingham to begin adult-use sales on Feb. 29 - Green Thumb Industries announced it would begin adult-use cannabis sales at Rise Effingham on Saturday, February 29. This is the sixth GTI store to offer adult-use cannabis sales in Illinois. Rise Effingham has undergone significant renovation and expansion to accommodate distinct service areas specifically for adult-use customers and medical patients.

07:13 EST Intertape Polymer announces efforts for more sustainable future - Intertape Polymer Group announced a series of measures that demonstrate its continuing commitment to creating a more sustainable future by enhancing its product offering, operations and supply-chain management. As part of this comprehensive approach to sustainability, the Company has engaged William McDonough as a strategic advisor for the Company's sustainability strategy. This is in addition to implementing other measures to position the Company as a leading provider of sustainable packaging and protective solutions. Sustainability Highlights: Collaborating with William McDonough of McDonough Innovation on strategic advising for the design, manufacture and delivery of packaging and protective solutions grounded in the Cradle to Cradle Design framework; Achieved Cradle to Cradle Certified Bronze level for water-activated tape; Launched the Curby product line, a new proprietary, curbside recyclable range of solutions; Passed the Western Michigan University Old Corrugated Cardboard Equivalency testing protocol to certify the recyclability of IPG non-reinforced WAT; Published the Company's first annual Sustainability Report in 2019; Signed the United Nations Global Compactagreeing to adopt the ten principals governing Human Rights, Labor, Environment and Anti-Corruption; as a result, IPG expects all of its suppliers to support the Compact's Principals.

07:07 EST Wayfair reports 20.3M active customers, up 34% year-over-year

07:00 EST Independence Contract Drilling reports Q4 EPS (47c), consensus (9c) - Reports Q4 revenue $45.29M, consensus $44.5M. CEO Anthony Gallegos commented, "The fourth quarter of 2019 reflected a continued period of strategic market positioning for ICD. We successfully added drilling optimization software to three of our operating rigs during the quarter, completed two strategic rig upgrades, and exited the quarter enhancing our industry's efforts to address ESG concerns by utilizing bi-fuel systems on approximately half of our operating rigs. For the quarter, expected rig count gains and increasing momentum in the Permian were offset slightly by weakness in the Haynesville where depressed natural gas prices caused several key customers to alter planned drilling programs entering 2020."

06:55 EST Wesco announces expiration of HSR Act waiting period for Anixter merger - Wesco (WCC) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, as amended, in connection with its previously announced merger with Anixter (AXE), expired. The expiration of the HSR Act waiting period satisfies one of the conditions to the closing of the proposed transaction, which remains subject to other customary closing conditions, including receipt of Anixter stockholder approval and other regulatory approvals.

06:42 EST Digital Realty increases quarterly dividend 4% to $1.12 per share - Digital Realty announced that its board of directors has authorized quarterly cash dividends for common and preferred stock for Q1. Digital Realty's board of directors authorized a cash dividend of $1.12 per share to common stockholders of record as of the close of business on March 17. The common stock cash dividend will be paid on March 31.

06:35 EST DPW Holdings unit terminates agreement to buy two broker-dealers - DPW Holdings announced on January 2, that its wholly owned subsidiary, DPW Financial Group, had entered into an agreement to acquire two broker-dealers, consisting of Glendale Securities, a retail broker-dealer, and its correspondent clearing broker dealer. DPW also announced that the closing of the agreement was subject to customary conditions, including regulatory clearance, which consisted principally of approval by the Financial Industry Regulatory Authority,. On January 8, the company announced that on January 7, the Firms had held a telephonic meeting with representatives of FINRA and that they were informed that the proposed transaction would not be approved in its then contemplated form. As a result, the Firms had withdrawn their respective applications seeking FINRA's approval of the agreement. The company reviewed the information it was provided by GSI and, after evaluating its options with respect to the agreement, decided to terminate the agreement and not pursue the acquisition of the Firms.

06:28 EST Occidental Petroleum sees FY20 total company production 1,360-1,390 Mboed - Sees FY20 Permian resources production 465-475 Mboed, with international production 242-250 Mboed.

06:26 EST Occidental Petroleum 'on track' to meet or exceed $1.2B in annualized synergies - Says on track to meet or exceed targets, including $1.2B in annualized synergies, $7B debt reduction and $10.2B in announced divestitures. The company is targeting 20+% CROCE. Comments taken from Q4 earnings conference call presentation slides.

06:10 EST Verastem says sees FY20 OpEx down approximately 40% y/y - As a result of its strategic realignment, Verastem Oncology expects to reduce its operating expenses by approximately 40% for 2020 compared to 2019. Based on its current operating plans, Verastem Oncology expects its research and development and selling, general and administrative expenses for the full year 2020 to be in the range of $70M-$85M. As of December 31, 2019, Verastem Oncology had preliminary unaudited cash and short-term investments of $111.3M. As announced today, Verastem Oncology anticipates completing a private placement of approximately 46.5M shares of its common stock at an offering price of $2.15 per share on March 3, 2020, resulting in gross proceeds of approximately $100M to Verastem Oncology before deducting expenses to the placement agents and other estimated offering expenses. Verastem Oncology expects that its existing cash and cash equivalents, along with the revenue it expects to generate from COPIKTRA, will be sufficient to fund its planned operations into the fourth quarter of 2021.

06:06 EST W.R. Grace raises share repurchase authorization to $250M - W. R. Grace announced that its Board of Directors increased its share repurchase authorization to $250M, including approximately $83M remaining under its previously-announced program. In the first quarter, Grace has repurchased more than $25M of its common stock. Since February 2014, the company has repurchased approximately $1.2B of its common stock.

05:19 EST Coty appoints Pierre Denis as CEO, CFO Pierre-Andre Terisse adds COO duties - Coty announced several executive and board appointments that are designed to help accelerate growth of the business. By summer 2020, upon conclusion of the strategic review that is underway, Pierre Denis will succeed Pierre Laubies as CEO of Coty and Pierre-Andre Terisse, CFO of Coty, will become COO while retaining in full his CFO role and responsibilities. Additionally, the Coty board has elected Isabelle Parize and Justine Tan non-executive directors, effective February 27.